Oxidative stress may contribute to cardiac ryanodine receptor (RyR2) dysfunction in heart failure (HF) and arrhythmias. Altered RyR2 domain-domain interaction (domain unzipping) and calmodulin (CaM) binding affinity are allosterically coupled indices of RyR2 conformation. In HF RyR2 exhibits reduced CaM binding, increased domain unzipping and greater SR Ca leak, and dantrolene can reverse these changes. However, effects of oxidative stress on RyR2 conformation and leak in myocytes are poorly understood. We used fluorescent CaM, FKBP12.6, and domain-peptide biosensor (F-DPc10) to measure, directly in cardiac myocytes, (1) RyR2 activation by hydrogen peroxide (H 2 O 2 )-induced oxidation, (2) RyR2 conformation change caused by oxidation, (3) CaM-RyR2 and FK506-binding protein (FKBP12.6)-RyR2 interaction upon oxidation, and (4) whether dantrolene affects 1-3. H 2 O 2 was used to mimic oxidative stress. H 2 O 2 significantly increased the frequency of Ca 2+ sparks and spontaneous Ca 2+ waves, and dantrolene almost completely blocked these effects. H 2 O 2 pretreatment significantly reduced CaM-RyR2 binding, but had no effect on FKBP12.6-RyR2 binding. Dantrolene restored CaM-RyR2 binding but had no effect on intracellular and RyR2 oxidation levels. H 2 O 2 also accelerated F-DPc10-RyR2 association while dantrolene slowed it. Thus, H 2 O 2 causes conformational changes (sensed by CaM and DPc10 binding) associated with Ca leak, and dantrolene reverses these RyR2 effects. In conclusion, in cardiomyocytes, H 2 O 2 treatment markedly reduces the CaM-RyR2 affinity, has no effect on FKBP12.6-RyR2 affinity, and causes domain unzipping. Dantrolene can correct domain unzipping, restore CaM-RyR2 affinity, and quiet pathological RyR2 channel gating. F-DPc10 and CaM are useful biosensors of a pathophysiological RyR2 state.
Introduction
The Ca 2+ release channel in cardiac sarcoplasmic reticulum (SR) is the type 2 ryanodine receptor (RyR2), which is pivotal in cardiac excitation-contraction coupling [1] . Several lines of evidence suggest that excessive Ca 2+ leak through RyR2, in diastole, is seen in pathological conditions, such as heart failure (HF), leading to both systolic and diastolic dysfunction [2] [3] [4] [5] [6] [7] . This abnormal RyR2 Ca 2+ leak can cause delayed afterdepolarization (DAD) that can lead to lethal arrhythmias, such as catecholaminergic polymorphic ventricular tachycardia (CPVT) that is linked to human RyR2 mutations. Stabilization of RyR2 closed state, resulting in suppression of abnormal SR Ca 2+ leak, is a promising new therapeutic strategy against HF or lethal arrhythmias.
In our recent studies, we have proposed that altered RyR2 conformation, especially of an interaction between the N-terminal and central domains of the RyR2, destabilizes the RyR2 channel gating and contributes to the abnormal Ca 2+ leak [4, [8] [9] [10] [11] [12] . In normal conditions, the interaction between these domains is tight (zipped state), and stabilizes the closed RyR2 channel. On the other hand, in disease conditions, the interaction between N-terminal and central domains is weakened (unzipped state), resulting in an abnormally high Ca 2+ leak via RyR2. This altered domain interaction (domain unzipping) may be diagnostic of a pathological RyR2 gating state that contributes to dysfunction. A domain peptide corresponding to a sequence span within the central domain of RyR2 residues 2460-2495 (DPc10), that includes a CPVT mutation site (R2474S), can bind to the native N-terminal domain, competing with its normal interaction with the central domain. By inducing domain unzipping, DPc10 increases RyR2 leakiness in the normal cardiac myocytes or SR vesicles [4, 11] . We have recently proposed that the binding kinetics of fluorescent DPc10 (F-DPc10) to the RyR2 in permeabilized cardiomyocytes is a sensitive measure of RyR2 conformational change to the pathological unzipped state [12] .
Calmodulin (CaM) binds to and inhibits RyR2 opening at both high and low [Ca 2+ ] [13, 14] . We have shown that CaM-RyR2 binding affinity is reduced in HF [3, 15] and that this increases RyR2 Ca 2+ leak, as seen in HF or in knock-in (KI) mice carrying a human CPVT-associated RyR2 mutation (R2474S) or an RyR2 mutation that prevents CaM binding [15, 16] . We also showed that CaM binding to RyR2 stabilizes the zipped state, suppresses DPc10 access and inhibits RyR2 leak. Reciprocally, domain unzipping inhibits CaM-RyR2 binding, which in turn causes abnormal Ca 2+ leak from RyR2 [12] .
Reactive oxygen species (ROS) are thought to be involved in a variety of cardiovascular diseases, including HF [17] [18] [19] . ROS can also cause RyR2 dysfunction by oxidation of thiol groups of cysteine residues in the RyR2 channel [20] . However, the relation between oxidationinduced RyR2 dysfunction and either CaM binding affinity or the pathological unzipped state is not clear, especially in the myocyte environment.
Dantrolene is the only specific and effective therapeutic agent for treatment of malignant hyperthermia that occurs in certain patients during or following surgery or anesthesia [21] . In HF or CPVT-KI mouse, dantrolene has been reported to correct domain unzipping by binding to the N-terminal (601-620) domain of RyR2, and thereby inhibit diastolic Ca 2+ leak via RyR2 [11, 22, 23] .
In the present study, we investigated directly in cardiac myocytes how moderate oxidative stress, as in HF, alters RyR2 conformation, as detected by measuring the fluorescently labeled DPc10 (F-DPc10) binding kinetics, and the binding affinity of fluorescent CaM and FKBP12.6. Furthermore, we assessed how dantrolene affects RyR2 conformation change and the binding affinity of CaM-RyR2 and FKBP12.6-RyR2.
Materials and methods
Rat ventricular myocytes were isolated and permeabilized as previously described [24] . The care of the animals and procedures were approved by the University of California, Davis Animal Research Committee in accordance with the NIH Guide for the Care and Use of Laboratory Animals, and Guidelines of the Animal Ethics Committee of Yamaguchi University School of Medicine. FKBP12.6 and CaM were labeled with Alexa Fluor 488 (F-FKBP12.6, F-CaM, respectively) and DPc10 was labeled with HiLyte Fluor 647 (F-DPc10, respectively) at AnaSpec as in our previous studies [12, 25, 26] . Online Fig. IA -C shows hydrogen peroxide (H 2 O 2 ) did not alter both AF488 and F-CaM fluorescence intensity. All experiments were performed at room temperature (25°C). An expanded Materials and Methods section can be found in the Online Data Supplement. We assessed the molecular mechanism by which RyR2 activity was increased by H 2 O 2 -induced oxidative stress. FKBP12.6 can bind to and stabilize RyR2 channel gating, but details are controversial [33] . We measured the effect of H 2 O 2 on FKBP12.6-RyR2 binding affinity in saponin-permeabilized myocytes using AF488-FKBP12.6 [15, 25, 26, 34, 35] . 
Results

Activated RyR2 function by oxidation in myocytes
Effect of H 2 O 2 on CaM binding to Z-line in permeabilized myocytes
CaM also binds to RyR2 and reduces RyR2 open probability, and works as a regulatory protein for RyR2 channel gating [13] [14] [15] 36] . We measured the effect of H 2 O 2 on CaM-RyR2 binding affinity using F-CaM as in our previous reports [15, 25] . Fig. 5A -B shows that both 10 and 50 μM H 2 O 2 myocyte pretreatment reduced the F-CaM binding at the Z-line significantly, (using [F-CaM] = 20 nM, near its K d [15] ), but did not alter CaM at the M-line (Online Fig. IIA) . This indicates that H 2 0 2 decreased affinity of F-CaM/RyR2 binding. However, because H 2 O 2 was not removed before CaM addition, this effect might be due to oxidation of either RyR2 or CaM, particularly because methionines on CaM can be oxidized and cause reduced binding to RyR2 [36] .
To test whether CaM oxidation can explain the reduced RyR2 binding of H 2 O 2 -treated myocytes, we first incubated [F-CaM] (50 μM) for 60 min in media containing 50 μM H 2 O 2 (the concentration used in pre-incubated myocytes). This allowed F-CaM oxidation (and we call this F-CaM washing, prior to the addition of F-CaM. IIB) . That is consistent with data in Fig. 5 , and that~60% of the reduced CaM binding in Fig. 5B of RyR2 and CaM and reduced CaM binding to the RyR2. The restoration of CaM binding (and normal Ca sparks) by dantrolene raised a connection to our recent work [12] . We had shown that RyR2 CaM binding exhibits negative allosteric coupling with the accessibility of the unzipping peptide DPc10 (DPc10 binding inhibits CaM binding, and CaM binding inhibits DPc10 access [12] ). Dantrolene may shift this balance toward the more normal state [22, 23] by reducing DPc10 accessibility (zipping) and also increasing CaM affinity. We tested whether H 2 O 2 treatment enhances DPc10 access and whether that was sensitive to dantrolene (as shown above for CaSpF and CaM binding). We previously reported that the wash-in kinetics of DPc10 labeled with HyLite Fluor 647 (F-DPc10) were greatly slowed when CaM was bound to RyR2, which also prevented RyR2 activation by DPc10 exposure [12] . Our working model was that DPc10 access to its binding site was sterically blocked when CaM was bound. Here, we first tested whether dantrolene has the same effect as CaM in preventing DPc10 access. Fig. 7A shows confocal images of F-DPc10 binding after 200 min of incubation. Fig. 7B shows the time course of F-DPc10 wash-in with or without 1 μM dantrolene. Dantrolene reduced maximal F-DPc10 binding (B max ) by N70% (Fig. 7C) , without altering M-line fluorescence (Online Fig. IV) . This suggests that dantrolene keeps RyR2 conformationally closed with respect to access of DPc10. However, these results could also be due to competition between F-DPc10 and dantrolene binding to a site on RyR2. To test this hypothesis, we measured the FDPc10 wash-out kinetics, with or without dantrolene. Online Fig. VA-B shows that non-fluorescent DPc10 (NF-DPc10) can accelerate the wash-out kinetics of F-DPc10. This is consistent with our previous report that F-DPc10 and NF-DPc10 bind at the same RyR2 site [12] . However, dantrolene had no effect on F-DPc10 wash-out kinetics, indicating that F-DPc10 and dantrolene binding sites are separate (Online Fig. VC-D) . This also suggests that the slow binding of F-DPc10 (and effect of dantrolene thereon) is due to on-rate effects, consistent with a RyR2 conformation that strongly limits access of DPc10 to its site on RyR2.
F-FKBP (1 nM)
F-CaM
Next, we tested whether RyR2 oxidation would increase F-DPc10 access. Here, we used FRET between F-FKBP12.6 as a donor and F-DPc10 as an acceptor, to detect DPc10 that specifically binds at RyR2 [12] . Note that F-FKBP12.6 binds specifically at RyR2 with 1 nM affinity, and its binding is not influenced by CaM [26] , H 2 O 2 or dantrolene (Fig. 4) . FRET was determined from the decrease in F-FKBP12.6 donor fluorescence intensity by binding of F-DPc10 acceptor in its proximity, i.e. donor quench, as in our previous report [12] . H 2 O 2 pre-incubation significantly accelerated the rate of F-DPc10 binding compared with control ( Fig. 8A-B) . This indicates that RyR2 oxidation enhances DPc10 access (e.g. by causing domain unzipping). Furthermore, preequilibration with dantrolene in H 2 O 2 -treated myocytes reversed the H 2 O 2 -induced acceleration of access (Fig. 8B) and reduced the maximal extent of quench (Fig. 8C) , which reflects a decrease in B max of F-DPc10. Taken together, these findings show, for the first time in situ, that H 2 O 2 leads to defective RyR2 domain unzipping and dantrolene can correct this conformational change as well as restoring CaM affinity.
Discussion
Novel findings of this study are the following: In permeabilized ventricular myocyte environment, (1) H 2 O 2 treatment increases both CaSpF and the occurrence of SCW, but dantrolene prevents this elevated Ca 2+ leak; (2) RyR2 oxidation by H 2 O 2 decreases its binding affinity for CaM, but does not alter its FKBP12.6 affinity; (3) RyR2 oxidation leads to domain unzipping (high DPc10 access); and (4) dantrolene corrects domain unzipping, restores the CaM-RyR2 binding affinity, and inhibits pathological RyR2 channel gating. Our working model is that modest H 2 O 2 (or ROS) levels cause a similar pathological change in RyR2 conformation as seen in HF, in which CaM affinity is reduced, DPc10 access is increased and SR Ca leak is elevated.
RyR2 function is activated by H 2 O 2
Increased ROS production has been associated with pathological states, such as HF [39] , and RyR2 activity in pathological states is increased by thiol oxidation [40, 41] transient (reflecting NCX activity), were similar. This indicates that both SERCA and NCX function were not appreciably altered under our specific conditions. Thus, RyR2 function may be more sensitive to H 2 O 2 -induced modulation than are SERCA or NCX. We also found a significant increase in the occurrence of arrhythmogenic SCW in H 2 O 2 -treated myocytes, when pacing rate increased from 1 to 5 Hz, indicating that hyperactivity of RyR2 by oxidation may contribute to triggering lethal arrhythmias.
Dantrolene reverses H 2 O 2 -induced RyR2 activation without altering cellular and RyR2 oxidation
Dantrolene has been shown to bind to amino acids 601-620 of RyR2 [42] and stabilize the RyR2 channel gating in pathological states, such as HF [32] or CPVT [43] . However, dantrolene has no effect on Ca 2+ signaling under control condition [32, 44] . These are consistent with our observation that dantrolene significantly reduced the CaSpF and prevented potentially deleterious spontaneous arrhythmogenic Ca 2+ waves in H 2 O 2 -treated myocytes, but did not alter the frequency of Ca 2+ sparks and SCW under control condition. To exclude the possibility that dantrolene attenuated the oxidation level to achieve this effect, we measured intracellular ROS production and RyR2 free thiol content in dantrolene-treated myocytes. Dantrolene influenced neither cellular nor RyR2 Cys oxidation level, suggesting that dantrolene directly stabilized RyR2, possibly by inhibiting domain unzipping [22] . Conceivably, dantrolene may indirectly affect RyR2 function via Met oxidation. However, the lack of significant effects on the overall cell oxidation and on the RyR2 Cys oxidation makes this an unlikely mechanism of dantrolene action. [37] reported that extensive in vitro oxidation of CaM abolishes the functional interaction between CaM and RyR2. That is consistent with our in situ observation that our much milder exposure to H 2 O 2 caused some CaM oxidation and reduction of binding to RyR2 (Fig. 5C ). On the other hand, it has been previously proposed [14] that RyR2 oxidation enhances RyR2 activity by decreasing CaM binding affinity. This also agrees with our myocyte result that RyR2 oxidation reduced subsequent CaM binding (Fig. 6) . Taken together, these results strongly support the conclusion that oxidation of both CaM and RyR2 cause reduced CaM-RyR2 binding and this combined mechanism contributes to RyR2 dysfunction during oxidative stress. One of the interesting findings here is that dantrolene restores the CaM-RyR2 binding in H 2 O 2 -treated myocytes, resulting in lower resting RyR2 leak, as has been seen for dantrolene in HF or CPVT models [45, 23] , without changing intracellular and RyR2 oxidative level (Fig. 3) .
FKBP12.6 binds to RyR2 with high affinity and can also influence RyR2 gating [26, 46, 47] , and has been proposed to play an important role in stabilizing RyR2 function [46] [47] [48] , although this issue is controversial [26, 30, 49, 50] . Shan et al. reported [48] that 1 mM H 2 O 2 combined with phosphorylation of Ser2808 by PKA could reduce FKBP12.6 binding to RyR2 by~70%. In contrast, we find that neither PKA-dependent phosphorylation [26] , DPc10-induced unzipping [12] nor the more moderate levels of H 2 O 2 used here (plausibly reflective of HF myocyte) had any effect on FKBP12.6 binding to RyR2 in myocytes (Fig. 4) . In our hands, CaM has much stronger effects on RyR2 function than does FKBP12.6, with more pronounced changes during pathophysiological conditions such as HF [15] , oxidation or DPc10-induced unzipping.
Dantrolene corrects RyR2 conformation caused by either H 2 O 2 or DPc10
We previously demonstrated that monitoring F-DPc10 binding kinetics is a powerful tool to evaluate functionally important RyR2 conformational changes, likely related to an interaction between the Nterminal and central domains of RyR2. Using this method, we now show that H 2 O 2 significantly accelerates F-DPc10 association rate in situ, indicating that H 2 O 2 causes domain unzipping (Fig. 8) . We also found that dantrolene reduces access of F-DPc10 in either H 2 O 2 -or DPc10-treated myocytes, which suggests that H 2 O 2 and DPc10 induce similar structural changes that are both corrected by dantrolene (Figs. 7 and 8 ). These findings are consistent with previous in vitro reports that oxidative stress of RyR2 (in SR vesicles) weakens domain interactions [51] and that dantrolene improves RyR2 function via correcting domain unzipping [22] . The B max for F-DPc10 is lower in dantrolene-treated myocytes. That could have been a result of DPc10 and dantrolene competing at the same site. But we have ruled out that possibility. First, we measured the wash-out kinetics of F-DPc10 with or without NF-DPc10 in wash-out solution. Since F-DPc10 wash-out rate was faster with NF-DPc10 (Online Fig. VA-B) , we infer that FDPc10 and NF-DPc10 bind to RyR2 at the same site. In contrast, dantrolene did not alter the wash-out kinetics of F-DPc10. These results suggest that dantrolene prevents F-DPc10 access (drastically reducing on-rate) without altering F-DPc10 dissociation (off-rate) (Online Fig. VC-D) . This observation supports the conclusions that F-DPc10 and dantrolene bind at separate sites on RyR2, and that dantrolene, like CaM [12] , influences DPc10 access by an allosteric mechanism.
Limitations
CaMKII can also be activated by oxidation at methionine 281/282 [52] and can also phosphorylate and activate RyR2 in pathological states [3, 38, [52] [53] [54] . This CaMKII pathway would be expected to exacerbate the direct ROS effects on CaM and RyR2 that alter RyR2 gating that has been our focus here. Here, we used the CaMKII inhibitors AIP (CaM binding experiments) and 
Conclusion
Our results indicate that abnormal oxidative modification of RyR2 by H 2 O 2 causes reduced CaM affinity of RyR2 (by oxidation of sites on both CaM and RyR2) and RyR2 conformation changes (domain unzipping) that lead to untimely and potentially arrhythmogenic RyR2 channel opening. Dantrolene restores normal CaM binding and conformational state, and quiets pathological RyR2 channel gating (but has no effect on RyR2 function under control normal conditions). This H 2 O 2 -induced structural unzipping, reduced CaM binding and more active RyR2 may represent a functionally integrated common pathological RyR2 state that is relevant for HF, oxidative stress and even CPVTlinked genetic mutations.
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